This issue of Medical Clinics of North America, edited by Dr. Irl Hirsch, is devoted to Diabetes Management. Articles in this issue include: Diabetes Classification Update; Internet Diabetes Management: An Effective, Efficient, and Cost Effective Approach; Monitoring Glycemia in Diabetes; Glycemic Targets: What is the Evidence?; Lifestyle Modification in Diabetes; Metformin, Sufonlyureas, Acarbose, Thiazolidnediones, Bromocriptine, and Colesevalam; Incretins; SGLT-2 inhibitors; Insulin therapy in Type 1 Diabetes; Insulin Therapy in Type 2 Diabetes; Non-Glycemic Targets for Patients with Diabetes; Screening and Treatment for the Primary Care Provider of Common Diabetes Complications; and Polycystic Ovarian Syndrome.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. CME Accreditation Page - p. 5 6. Forthcoming Issues - p. 6 7. Contributors - p. 7 8. Foreword: Diabetes Management - p. 10 9. Preface: Diabetes Management - p. 11 10. Erratum - p. 12 11. Update on Diabetes Classification - p. 13 12. Internet Blood Glucose Monitoring Systems Provide Lasting Glycemic Benefit in Type 1 and 2 Diabetes - p. 23 13. Monitoring Glycemia in Diabetes - p. 31 14. Glycemic Targets - p. 37 15. Lifestyle Intervention - p. 47 16. Oral Antihyperglycemic Treatment Options for Type 2 Diabetes Mellitus - p. 56 17. Incretin-Based Therapies - p. 68 18. Sodium Glucose Cotransporter 2 Inhibitors - p. 79 19. Insulin Therapy in Type 1 Diabetes - p. 87 20. Insulin Tactics in Type 2 Diabetes - p. 94 21. Nonglycemic Targets in Diabetes - p. 108 22. Screening and Treatment by the Primary Care Provider of Common Diabetes Complications - p. 116 23. Polycystic Ovarian Syndrome - p. 126 24. Index - p. 134
No hay muestra disponible
No hay ficha técnica disponible
This issue of Medical Clinics of North America, edited by Dr. Irl Hirsch, is devoted to Diabetes Management. Articles in this issue include: Diabetes Classification Update; Internet Diabetes Management: An Effective, Efficient, and Cost Effective Approach; Monitoring Glycemia in Diabetes; Glycemic Targets: What is the Evidence?; Lifestyle Modification in Diabetes; Metformin, Sufonlyureas, Acarbose, Thiazolidnediones, Bromocriptine, and Colesevalam; Incretins; SGLT-2 inhibitors; Insulin therapy in Type 1 Diabetes; Insulin Therapy in Type 2 Diabetes; Non-Glycemic Targets for Patients with Diabetes; Screening and Treatment for the Primary Care Provider of Common Diabetes Complications; and Polycystic Ovarian Syndrome.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. CME Accreditation Page - p. 5 6. Forthcoming Issues - p. 6 7. Contributors - p. 7 8. Foreword: Diabetes Management - p. 10 9. Preface: Diabetes Management - p. 11 10. Erratum - p. 12 11. Update on Diabetes Classification - p. 13 12. Internet Blood Glucose Monitoring Systems Provide Lasting Glycemic Benefit in Type 1 and 2 Diabetes - p. 23 13. Monitoring Glycemia in Diabetes - p. 31 14. Glycemic Targets - p. 37 15. Lifestyle Intervention - p. 47 16. Oral Antihyperglycemic Treatment Options for Type 2 Diabetes Mellitus - p. 56 17. Incretin-Based Therapies - p. 68 18. Sodium Glucose Cotransporter 2 Inhibitors - p. 79 19. Insulin Therapy in Type 1 Diabetes - p. 87 20. Insulin Tactics in Type 2 Diabetes - p. 94 21. Nonglycemic Targets in Diabetes - p. 108 22. Screening and Treatment by the Primary Care Provider of Common Diabetes Complications - p. 116 23. Polycystic Ovarian Syndrome - p. 126 24. Index - p. 134
No hay muestra disponible
No hay ficha técnica disponible
